Impact of intracoronary adenosine on the no-reflow phenomenon: A randomized, triple-blind, placebo-controlled clinical trial.

Am Heart J Plus · 2025 · PMC12595116 · PMID 41211128

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

did not reach statistical significancep = 0.089so close (0.05 < p ≤ 0.1)

15.0 ± 8.1), although this difference did not reach statistical significance ( p = 0.089).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.